Drugs to suppress cough

Author: K F Chung

Source: Expert Opinion on Investigational Drugs, Volume 14, Number 1, 1 January 2005 , pp. 19-27(9)

Buy & download fulltext article:

Price: $99.00 plus tax (Refund Policy)

Abstract:

Cough is an important defensive reflex of the airway and also a common symptom of respiratory disease. Cough after common respiratory virus infection is transient but is more persistent when associated with conditions such as asthma, rhinosinusitis, gastro-oesophageal reflux, chronic obstructive pulmonary disease and lung cancer. Persistent cough may be due to peripheral and/or central sensitisation of cough reflexes initiated by cough receptors, rapidly adapting receptors or nociceptors. Treatment directed at associated conditions such as asthma (with anti-inflammatories) and gastro-oesophageal reflux (with proton-pump inhibitors) improve cough. There remains a need to use drugs that suppress the neural activity of cough (termed nonspecific), as treatments directed at the clinical cause(s) of the underlying cough (termed specific) may not be effective. The most effective indirect antitussives are opioids such as morphine, codeine or pholcodeine, but they produce side effects such as drowsiness, nausea, constipation and physical dependence. Opioids such as kappa

- and

-receptor agonists, non-opioids such as nociceptin, neurokinin and bradykinin receptor antagonists, cannabinoids, vanilloid receptor-1 antagonists, blockers of Na+-dependent channels, and large conductance Ca²⁺-dependent K+-channel activators of afferent nerves may represent novel antitussives.

Keywords: antitussive; cough; cough receptor; opioids; cough reflex

Document Type: Review article

DOI: http://dx.doi.org/10.1517/13543784.14.1.19

Publication date: 2005-01-01

More about this publication?